Laboratorium Galenowe Olsztynsp. z o.o.

Manufacture of pharmaceutical preparations

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2001-07-06
Share capital
772 000,00 PLN
Registered address
Spółdzielcza 25/A, 11-001 Dywity, Poland
Electronic delivery address
AE:PL-49415-94195-SUEAH-19

Financials

Revenue history (in m)

Filing timeliness

4 of 6 financial statements were filed late (the longest delay 83 days for 2021). All were audited by a statutory auditor.

  • 202506/08/2026
  • 202411/07/2025
  • 202317/07/2024
  • 202226/07/2023
  • 202106/10/2022
  • 202004/08/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 23.67mMedianUSD 917.74kAverageUSD 25.73m
Net profit
This companyUSD 2.10mMedianUSD 14.44kAverageUSD 2.75m
Operating costs
This companyUSD 19.96mMedianUSD 860.03kAverageUSD 21.34m
Assets
This companyUSD 21.22mMedianUSD 883.09kAverageUSD 31.39m

Trademarks

Laboratorium Galenowe Olsztyn holds 4 active trademarks registered with the Polish Patent Office. 2 applications are pending. 10 marks have expired or were not registered. The first mark was filed in 1993.

MarkNumberClassesStatusProtected until
LGO(word)Z.5367833, 5, 10, 16, 35, 39, 42Protected Nov 22, 2031
Laboratorium Galenowe OlsztynZ.5201753, 5, 10, 16, 35, 39, 42Protected Jan 4, 2031
ENEMAZ.3623435Protected Nov 2, 2029
SIMET(word)Z.1259780, 5Protected Oct 19, 2033
LokoBalans(word)Z.6056745Application pending –
MarkProtected until
LGO(word)Nov 22, 2031
Laboratorium Galenowe OlsztynJan 4, 2031
ENEMANov 2, 2029
SIMET(word)Oct 19, 2033
LokoBalans(word)–

Authorized Representatives

Artur Janusz Krawczak – Management Board Member
Dorota Borowska – Management Board Member
Marcin Stypułkowski – Management Board Member
Sylwia Tobólska – Management Board Member

Manner of representation

If a multi-member management board is appointed, the joint action of two members of the management board or one member of the management board jointly with a commercial proxy is required for the validity of declarations made on behalf of the company. The commercial proxy makes declarations on behalf of the company jointly with a member of the management board or, if joint commercial proxy has been granted, with another commercial proxy.

Ownership

OwnerSharesShare valueStake
7,720$208,535.93100%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2001-07-15.

Debt

No entries in the National Debtors Register (KRZ).

Real estate

TypeAmount
Land (incl. perpetual usufruct)
$535.3K
Buildings and premises
$2.4M

Public aid

22 public aid cases recorded, with a total value of $10,820,399.

PurposeGross amount
Regional investment aid
$7.9M
Regional investment aid
$527K
De minimis aid (in accordance with Commission Regulation 2023/2831)
$31,881

European Funds

6 projects co-financed from European Funds recorded, with total EU co-financing of $9,447,316.

ProjectEU co-financing
Nanocapsulation of Lactobacillus rhamnosus GG – stable capsules without a cold chain.
$7.9M
Research on a liquid fertility supplement for women and men – an innovative approach to supporting reproductive health.
$490K
Integrated management of the material, financial, production and human resources of Laboratorium Galenowe Olsztyn Sp. z o.o. through the support of advanced digital technologies, including process automation.
$196.3K

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Change history

DateEvent
2005-07-14Address change
2002-12-11Address change
2002-06-07Share capital change
2001-10-30Name change
2001-07-06Entered in the register

FAQ

Last updated: 2026-10-07